SYNA · Desk conversation

Before the names, the shared picture is constructive: all three supplied equity benchmarks were higher and the VIX was lower. But breadth was unavailable, so we cannot say how many individual stocks joined the move.

The jobs report gives that backdrop some texture. Payrolls rose by 29,000, and July and August were revised down by 60,000 combined. That may affect rate expectations; it says nothing by itself about any one company's demand.

The 10-year yield finished the captured snapshot at 5.28%, up 4 basis points, after the public market report described a brief dip and rebound. So the rates signal was mixed even on a day when the broad indexes were up.

SYNA has the clearest company-specific event in this set: the sealed record describes a revised $123 cash offer per share. The stock rose about 14.30% on 8.83 times average volume. That is a strong reaction to document, not proof the deal will close.

The regular-session observation was above VWAP. That is the session's average traded price, weighted by volume; being above it means the stock traded above that average at the observation, not that the level guarantees future support.

My concern is the path from here. The price is already near the $123 consideration, and the move was 3.76 ATR from its EMA reference. The remaining upside may be limited while a changed or failed deal can still matter a great deal.

That asymmetry keeps me from calling it Try of the Day. The useful question is narrower: do the terms remain intact, and do subsequent public updates support completion? A model estimate cannot resolve that.

The active H15 estimate is 48.30%, but its adverse-MAE comparison has only eight cases, with a median of −7.88% and a P10 of −25.06%. Those are limited historical comparisons, not odds that this transaction succeeds.

INSG also has a concrete event: completion of Nokia's fixed-wireless business acquisition, with the company expecting roughly doubled revenue. Its observed move was positive, but the provider series faded after the regular session. The next operating evidence is still missing.

And the prepared balance-sheet snapshot for INSG shows $19.297 million in cash against $109.572 million in liabilities and negative equity. Those figures are dated context, but they make the integration thesis carry more risk.

PL offers a different research question: a launch of 20 satellites, including a prototype test of Google's AI chips in space, alongside an 8.43% initial scan-day move on 1.7 times average volume. A demonstration is not a customer order.

Right, and the record does not give us a dated commercial milestone to check next. VIAV and IMOS have stronger-looking price moves or relative strength, but their supplied event links do not establish an issuer-specific reason for those moves.

ALGM had a positive move and analyst commentary about data-center and automotive content, but that is not the same as issuer evidence of orders. ON's recorded move was below VWAP with a downward intraday slope, so the tape did not confirm continuation.

LLY has a specific FDA item in the sealed record, but its attached primary release is marked not safe for public use. The in-cut trajectory was muted. Later October 3 quotes are outside this decision cut and do not repair that evidence.

My current call is Raw Try on SYNA. The transaction makes a concrete case with a dated next check and a falsifier, but the near-offer price and completion risk prevent me from claiming a sufficiently supported favorable 15-session path.

Reopen: Please distinguish the eight-case historical adverse-MAE results from the separate SEC-aware modeled quantiles: the stated median and P10 belong to the model output, whose SEC inputs are not validated as point-in-time. Also correct Planet Labs’ comparison: the cited +8.43% move and 1.7× volume come from a later capture, while the October 2 record shows a different observation. Reassess the current Raw Try using those corrected statements.

Correction accepted. SYNA's historical H15 adverse-MAE distribution is the eight-case result: median −4.14%, P10 −11.82%. The separate SEC-aware modeled output is P50 −7.88%, P10 −25.06%; it has no supplied eight-case count, and its SEC inputs are not established as point-in-time.

Those are different measures, so the earlier sentence overstated what the eight-case sample supported. The model quantiles still show a wider adverse tail, but their SEC limitation matters. Neither measure tells us the probability that the acquisition closes.

There is also a date correction for PL. The October 2 regular-session trajectory records +9.20% on approximately 1.36 times average volume. The +8.43% and 1.7 times figures came from an October 3 capture and must not be presented as October 2 evidence.

That makes PL's in-cut price response stronger than our prior comparison said, though its volume ratio was lower. The launch and prototype test remain a technical event; the supplied record still does not connect them to a customer order or recurring revenue.

For SYNA, the active H3, H8, and H15 positive-return estimates are 46.00%, 47.30%, and 48.30%. They are model estimates, not deal-success odds. The separate adverse-tail outputs and their limitations need to stay beside them if we mention them.

I retain the current Raw Try on SYNA. The corrected figures reduce the apparent weight of the historical downside sample, and corrected PL data improves that alternative, but neither correction removes SYNA's proximity to the cash consideration or resolves completion risk. The selected identity and case remain unchanged.